Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data

Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data

Abstract The identification of non-small cell lung cancer (NSCLC) patients who will benefit from immunotherapy remains a clinical challenge. Monitoring real-world data (RWD) in the first cycles of therapy may provide a more accurate representation of response patterns in a real-world setting. We pro...

Full description

Bibliographic Details
Main Authors: Ana D. Ramos-Guerra, Benito Farina, Jaime Rubio Pérez, Anna Vilalta-Lacarra, Jon Zugazagoitia, Germán Peces-Barba, Luis M. Seijo, Luis Paz-Ares, Ignacio Gil-Bazo, Manuel Dómine Gómez, María J. Ledesma-Carbayo
Format: Article
Language:English
Published: Springer 2025-02-01
Series:Cancer Immunology, Immunotherapy
Subjects:
Non-small-cell lung cancer
Peripheral blood biomarker
Immunotherapy
Longitudinal analysis
Prognostic marker
Real-world data
Online Access:https://doi.org/10.1007/s00262-025-03966-9

Internet

https://doi.org/10.1007/s00262-025-03966-9

Similar Items